Clinical Trial Update: Infusion of Expanded Cord Blood T Cells [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the infusion of expanded cord blood T cells for stem cell transplantation in leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Expanded cord blood T cells (expanded cord blood T cells)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stem Cell Transplantation, Leukemia | Phase 1 | Status: WITHDRAWN